Close
  Indian J Med Microbiol
 

Figure 2: Attainment of low-density lipoprotein-cholesterol goals in the overall cohort, and in patients with primary and secondary prevention, metabolic syndrome, familial hypercholesterolemia, and peripheral arterial disease. Primary prevention P = 0.35; Secondary prevention: P = 0.062; Familial hypercholesterolemia (FH): P = 0.50; Metabolic syndrome: 0.33; Peripheral artery disease: P = 0.42

Figure 2: Attainment of low-density lipoprotein-cholesterol goals in the overall cohort, and in patients with primary and secondary prevention, metabolic syndrome, familial hypercholesterolemia, and peripheral arterial disease. Primary prevention <i>P</i> = 0.35; Secondary prevention: <i>P</i> = 0.062; Familial hypercholesterolemia (FH): <i>P</i> = 0.50; Metabolic syndrome: 0.33; Peripheral artery disease: <i>P</i> = 0.42